Conference on ‘ Diet , gene regulation and metabolic disease ’ Symposium 2 : Micronutrients , phytochemicals , gene expression and metabolic disease Polyphenols and non-alcoholic fatty liver disease : impact and mechanisms

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Pathways in Non-Alcoholic Fatty Liver Disease: An Emerging Menace

  2017cited by this paper
• Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.

  2015cited by this paper
• Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low‐grade inflammation and the development of obesity and diabetes

  2015cited by this paper
• Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance

  2014cited by this paper
• Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update

  2014cited by this paper
• Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans.

  2014cited by this paper
• Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

  2014cited by this paper
• Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.

  2014cited by this paper
• Resveratrol does not benefit patients with nonalcoholic fatty liver disease.

  2014cited by this paper
• Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.

  2014cited by this paper
• Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2014cited by this paper
• Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

  2014cited by this paper
• Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease.

  2014cited by this paper
• Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.

  2014cited by this paper
• World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

  2014cited by this paper
• Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases

  2013cited by this paper
• Fatty acid-regulated transcription factors in the liver.

  2013cited by this paper
• Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content

  2013cited by this paper
• From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

  2013cited by this paper
• Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis.

  2013cited by this paper
• Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation

  2013cited by this paper
• Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines

  2013cited by this paper
• Report Title: The burden of liver disease in Europe: a review of available epidemiological data

  2013cited by this paper
• Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis

  2013cited by this paper
• PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

  2013cited by this paper
• Modulation of metabolic syndrome-related inflammation by cocoa.

  2013cited by this paper
• Free radical biology for medicine: learning from nonalcoholic fatty liver disease.

  2013cited by this paper
• Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.

  2013cited by this paper
• Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.

  2013cited by this paper
• 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.

  2013cited by this paper
• Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice.

  2013cited by this paper
• Procyanidin B2 induces Nrf2 translocation and glutathione S-transferase P1 expression via ERKs and p38-MAPK pathways and protect human colonic cells against oxidative stress

  2012cited by this paper
• Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2012cited by this paper
• A Polyphenol Extract of Hibiscus sabdariffa L. Ameliorates Acetaminophen-Induced Hepatic Steatosis by Attenuating the Mitochondrial Dysfunction in Vivo and in Vitro

  2012cited by this paper
• Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.

  2012cited by this paper
• Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.

  2012cited by this paper
• Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.

  2012cited by this paper
• Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

  2012cited by this paper
• Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

  2012cited by this paper
• Moro orange juice prevents fatty liver in mice.

  2012cited by this paper
• Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats

  2011cited by this paper
• Comparative effects of dietary flavanols on antioxidant defences and their response to oxidant-induced stress on Caco2 cells

  2011cited by this paper
• Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells.

  2011cited by this paper
• Adiponectin, a key adipokine in obesity related liver diseases.

  2011cited by this paper
• Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice.

  2011cited by this paper
• Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice

  2011cited by this paper
• Reduction of lipid accumulation in HepG2 Cells by luteolin is associated with activation of AMPK and Mitigation of oxidative stress

  2011cited by this paper
• Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.

  2011cited by this paper
• Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

  2011cited by this paper
• Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ[S]

  2011cited by this paper
• Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro.

  2011cited by this paper
• Fatty liver: role of inflammation and fatty acid nutrition.

  2010cited by this paper
• A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat–high-sucrose diet-fed rats: possible implication of the sirtuin pathway

  2010cited by this paper
• Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins

  2010cited by this paper
• The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.

  2010cited by this paper
• AMP-activated protein kinase and its downstream transcriptional pathways

  2010cited by this paper
• Resveratrol commonly displays hormesis: Occurrence and biomedical significance

  2010cited by this paper
• AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol

  2009cited by this paper
• The challenge of developing novel pharmacological therapies for non‐alcoholic steatohepatitis

  2009cited by this paper
• Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.

  2009cited by this paper
• Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.

  2009cited by this paper
• Selective versus total insulin resistance: a pathogenic paradox.

  2008cited by this paper
• Insulin resistance, inflammation, and non-alcoholic fatty liver disease.

  2008cited by this paper
• Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort

  2008cited by this paper
• Resveratrol inhibits nonalcoholic fatty liver disease in rats

  2008cited by this paper
• Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease.

  2008cited by this paper
• Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

  2008cited by this paper
• A human hepatocellular in vitro model to investigate steatosis.

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes.

  2005cited by this paper
• Flavonoids: antioxidants or signalling molecules?

  2004cited by this paper
• Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

  2001cited by this paper
• Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I.

  1983cited by this paper

• Associations Between Coffee Consumption and the Prevalence of Metabolic Syndrome: A Nationwide Cross-Sectional Survey of Taiwanese Adults

  2026cites this paper
• Herbal remedies for hepatic diseases: A review of medicinal herbs in the treatment of liver disorders

  2026cites this paper
• Evaluation of Aqueous Maceration and Ultrasound-Assisted Extracts of Physalis philadelphica Lam. Solanaceae Husk on Hyperglycemia, Insulin Resistance, Hepatic Steatosis, and Oxidative Stress Markers in Obese Rats

  2025cites this paper
• Systematic Review of the Effects of Plant-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities Such as Obesity, Metabolic Syndrome, and Type 2 Diabetes

  2025cites this paper
• The polyphenol-rich plant extract Totum-448 decreases hepatic steatosis and inflammation in diet-induced MASLD mice

  2025cites this paper
• In silico and in vitro investigations reveal pan-PPAR agonist activity and anti-NAFLD efficacy of polydatin by modulating hepatic lipid-energy metabolism

  2025cites this paper
• In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model

  2025cites this paper
• The role of bioactive compounds in the management of metabolic and alcohol-related liver disease.

  2025cites this paper
• Argan Fruit Polyphenols Regulate Lipid Homeostasis, Prevent Liver Fat Accumulation, and Improve Antioxidant Defense in High-Calorie Diet Fed Mice: In Vivo Study and In Silico Prediction of Possible Underlying Mechanisms

  2025cites this paper
• An oligosaccharide isolated from Rosa canina ameliorates lipid profile and liver damage in MASLD modeled rabbits: in vivo and in silico studies

  2025cites this paper
• Phytochemical Composition of Ziziphus lotus (L.) Lam and Its Impact on the Metabolic Syndrome: A Review

  2025cites this paper
• Association of dietary quality and mortality in the non-alcoholic fatty liver disease and advanced fibrosis populations: NHANES 2005–2018

  2025cites this paper
• Marine natural products as an important source of bioactive substances for non-alcoholic fatty liver disease management

  2025cites this paper
• Nutrition in MASLD: a patient focused, evidence-based clinician’s guide

  2025cites this paper
• Pharmacology of bioactive compounds from plant extracts for improving non-alcoholic fatty liver disease through endoplasmic reticulum stress modulation: A comprehensive review

  2024cites this paper
• Effects of Cynara scolymus L. Bract Extract on Lipid Metabolism Disorders Through Modulation of HMG-CoA Reductase, Apo A-1, PCSK-9, p-AMPK, SREBP-2, and CYP2E1 Expression

  2024cites this paper
• Nutraceutical Properties of Thai Mulberry (Morus alba L.) and Their Effects on Metabolic and Cardiovascular Risk Factors in Individuals with Obesity: A Randomized, Single-Blind Crossover Trial

  2024cites this paper
• Phyllanthus urinaria water extract ameliorates lipid accumulation, oxidative stress and inflammation in chickens with fatty liver syndrome

  2024influential citation
• Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model

  2024cites this paper
• Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins

  2024cites this paper
• A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• A Novel Foodstuff Mixture Improves the Gut–Liver Axis in MASLD Mice and the Gut Microbiota in Overweight/Obese Patients

  2024cites this paper
• Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis

  2024cites this paper
• Polyphenol consumption and Nonalcoholic fatty liver disease risk in adults

  2024cites this paper
• Polyphenol-rich black currant and cornelian cherry juices ameliorate metabolic syndrome induced by a high-fat high-fructose diet in Wistar rats

  2024cites this paper
• Daraesoon (shoot of hardy kiwi) mitigates hyperglycemia in db/db mice by alleviating insulin resistance and inflammation

  2024cites this paper
• Effects of polyphenol supplementation on hepatic steatosis, intima-media thickness and non-invasive vascular elastography in obese adolescents: a pilot study protocol

  2024cites this paper
• Kiwifruit Peel Extract Improves the Alterations in Lipid Metabolism in High-fat Diet-fed Model Rats

  2024cites this paper
• Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials

  2023cites this paper
• Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver

  2023cites this paper
• Gut liver brain axis in diseases: the implications for therapeutic interventions

  2023cites this paper
• New Insights into Nutrition and Gut–Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

  2023cites this paper
• Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review.

  2023cites this paper
• Targeting Oxidative Stress with Polyphenols to Fight Liver Diseases

  2023cites this paper
• Adherence to Mediterranean Diet: Any Association with NAFLD?

  2023cites this paper
• Effect of Roselle Flower Extract (Hibiscus sabdariffa Linn.) on Reducing Steatosis and Steatohepatitis in Vitamin B12 Deficiency Rat Model

  2023cites this paper
• Effects of sumac supplementation on metabolic markers in adults with metabolic syndrome: a triple-blinded randomized placebo-controlled cross-over clinical trial

  2023cites this paper
• Plant-based diets in gastrointestinal diseases: Which evidence?

  2023cites this paper
• Serum from Adolescents with High Polyphenol Intake Exhibits Improved Lipid Profile and Prevents Lipid Accumulation in HepG2 Human Liver Cells

  2023cites this paper
• Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

  2023cites this paper
• Healthy Eating Index-2015 in relation to risk of metabolic dysfunction-associated fatty liver disease among US population: National Health and Nutrition Examination Survey 2017–2018

  2023cites this paper
• Unravelling the Helianthus tuberosus L. (Jerusalem Artichoke, Kiku-Imo) Tuber Proteome by Label-Free Quantitative Proteomics

  2022cites this paper
• Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

  2022cites this paper
• Bergamot (Citrus bergamia) leaf extract improves metabolic, antioxidant and anti-inflammatory activity in skeletal muscles in a metabolic syndrome experimental model

  2022cites this paper
• Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease

  2022cites this paper
• Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Association between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT Study

  2022cites this paper
• Polyphyllin I alleviates lipopolysaccharide-induced inflammation reduces pyroptosis in BEAS-2B and HPAEC cells by inhibiting NF-κB signaling.

  2022cites this paper
• Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet

  2022cites this paper
• SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1/ACC/FASN cascade.

  2022cites this paper
• Purple grumixama anthocyanins (Eugenia brasiliensis Lam.) attenuate obesity and insulin resistance in high-fat diet mice.

  2021cites this paper
• Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial

  2021cites this paper
• Chlorogenic Acid: A Promising Natural Agent for Non-Alcoholic Fatty Liver Disease Management

  2021cites this paper
• Effect of Diet on Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease

  2021cites this paper
• Oral Administration of Red Rice (Oryza nivara) Bran Extract Reduced Weight, Visceral Fat And Liver Steatosis Amount in Obesity Male Wistar Rats (Rattus norvegicus)

  2021influential citation
• Beneficial effects of Omega-3 polyunsaturated fatty acids in treatment of non-alcoholic fatty liver disease in rats.

  2021cites this paper
• Scolymus hispanicus (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty Diet

  2021cites this paper
• The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

  2021cites this paper
• Effect of Malus sylvestris Extract on Histopathological Features of Hypercholesterolemic Wistar Rat (Rattus norvegicus) Fatty Liver

  2021cites this paper
• Evaluation of the effects of additional therapy with Berberis vulgaris oxymel in patients with refractory primary sclerosing cholangitis and primary biliary cholangitis: A quasi-experimental study

  2021cites this paper
• A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?

  2020cites this paper
• Gibel gantzatsu ez-alkoholikoa, xxi. mendeko osasun-arazoa

  2020cites this paper
• Phenols fragment of Veronica ciliata Fisch. Ameliorate free radical-induced nonalcoholic fatty liver disease by mediating PI3K/Akt signaling pathway.

  2020cites this paper
• Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives.

  2020cites this paper
• Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease

  2020cites this paper
• Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.

  2020cites this paper
• Higher flavonoid intake is associated with a lower progression risk of non-alcoholic fatty liver disease in adults: a prospective study

  2020cites this paper
• Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity

  2020cites this paper
• The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)

  2020cites this paper
• Two polyphenol-rich Brazilian fruit extracts protect from diet-induced obesity and hepatic steatosis in mice.

  2020cites this paper
• Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation

  2020cites this paper
• Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis

  2020cites this paper
• Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet

  2020cites this paper
• The Association between Polyphenols Intake and Odds of Non-Alcoholic Fatty Liver Disease (NAFLD) among Adult Population

  2020cites this paper
• The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.

  2020cites this paper
• Whole Red Raspberry (Rubus idaeus)-Enriched Diet Is Hepatoprotective in the Obese Zucker Rat, a Model of the Metabolic Syndrome

  2020cites this paper
• The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

  2020cites this paper
• Dietary polyphenols and the odds of non-alcoholic fatty liver disease: A case-control study.

  2020cites this paper
• Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants

  2020influential citation
• Attenuation of Perfluorooctane Sulfonate-Induced Steatohepatitis by Grape Seed Proanthocyanidin Extract in Mice

  2020cites this paper
• DMSO_A_268146 3337..3348

  2020cites this paper
• Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times.

  2019cites this paper
• The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial

  2019cites this paper
• Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD

  2019cites this paper
• A chemically characterized ethanolic extract of Thai Perilla frutescens (L.) Britton fruits (nutlets) reduces oxidative stress and lipid peroxidation in human hepatoma (HuH7) cells

  2019cites this paper
• Ameliorative effect of dieckol-enriched extraction from Laminaria japonica on hepatic steatosis induced by a high-fat diet via β-oxidation pathway in ICR mice

  2019cites this paper
• Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.).

  2019cites this paper
• Active compounds of medicinal plants, mechanism for antioxidant and beneficial effects

  2019cites this paper
• Hepatoprotective Effect of Fresh Grape Juice Prepared by a Low-Speed Masticating Juicer in db/db Mice

  2019cites this paper
• Prospects for Using the Natural Antioxidant Compounds in the Obesity Treatment

  2019cites this paper
• The New Era of Nutraceuticals: Beneficial Effects of Polyphenols in Various Experimental and Clinical Settings.

  2019cites this paper
• The Role of Carbohydrate Response Element–Binding Protein in the Development of Liver Diseases

  2019cites this paper
• Plant flavonoids to improve productivity of ruminants – A review

  2019cites this paper
• Evaluation of lipotropic effect of herbal formulation on hepatic fat accumulation in rats fed with methionine-choline deficient diet

  2019cites this paper
• Polyphenol intakes and risk of impaired lipid profile, elevated hepatic enzymes and nonalcoholic fatty liver disease

  2019cites this paper
• Bioavailability and Pharmaco-therapeutic potential of luteolin in overcoming Alzheimer's disease.

  2019cites this paper